Clinical Trials Directory

Trials / Terminated

TerminatedNCT01223651

Performance of Continuous Glucose Monitoring Systems at Altitude

Performance of Continuous Glucose Monitoring Systems at Altitude.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
The Royal Bournemouth Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

10 healthy volunteers will undergo the controlled lowering of their blood glucose level at sea level and a simulated altitude of 8,000 feet, to test the hypothesis that continuous glucose monitoring system measurement of blood glucose is as accurate at altitude as at sea level.

Conditions

Interventions

TypeNameDescription
PROCEDUREtwo step hyperinsulinaemic glucose clamp study.Study participants will have their blood glucose stabilized between 5 - 6 mmol/L by the delivering of a controlled rate insulin/glucose infusion. Participants will have their blood glucose level reduced by conducting a controlled two step hyperinsulinaemic glucose clamp. The clamp procedure will take a total of 120 minutes and will reduce the blood glucose level to below 3 mmol/L. During this time blood tests will be obtained for analysis, physical observations recorded and cognitive function tests performed at regular intervals. Participants will have been fitted at least 12 hours prior to the intervention with 2 real time continuous glucose monitoring systems which will remain in place for the duration of the clamp procedure, however participants will be blinded to their glucose readings.

Timeline

Start date
2012-01-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2010-10-19
Last updated
2018-09-07

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01223651. Inclusion in this directory is not an endorsement.